PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmotion sickness
MeSH D009041 - motion sickness
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012816:Signs and symptoms
0 Companies
0 Drugs
Success rate
D009041: 
Motion sickness
D018489:Space motion sickness
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyDiphenhydramine Diphenhydramine  1982-01-01   
Abbott BiotherapeuticsPromethazine Promethazine  1982-01-01   
Able LaboratoriesPromethazine Promethazine  2003-02-27   
AllerganDiphenhydramine Diphenhydramine  1982-01-01   
Meclizine Meclizine  1982-01-01   
Promethazine Prometh  1982-01-01   
Promethazine Promethazine  2003-06-24   
Codeine, Promethazine Promethazine Codeine  1984-10-31   
AlpharmaCodeine, BROMODIPHENHYDRAMINE Bromanyl  1984-08-15   
Diphenhydramine Diphenhydramine  1989-04-25   
Diphenhydramine Hydramine  1986-01-28   
Promethazine Prometh Fortis  1982-01-01   
AlraDiphenhydramine Diphenhydramine  1982-01-01   
AltanaPromethazine Zipan  1982-01-01   
American RegentPromethazine Promethazine  2003-03-19   
Amneal PharmaceuticalsMeclizine Meclizine  2011-02-23   
Naproxen, Diphenhydramine Naproxen Diphenhydramine  2018-10-23   
Promethazine Promethazine  2009-12-30   
Codeine, Promethazine Promethazine Codeine  2013-04-24   
Dextromethorphan, Promethazine Promethazine Dextromethorphan  2011-02-08   
Phenylephrine, Codeine, Promethazine Promethazine Hydrochloride,phenylephrine W/codeine  2015-08-26   
Phenylephrine, Promethazine Promethazine Phenylephrine  2009-08-25   
ANI PharmaceuticalsMeclizine Meclizine  1982-01-01   
Phenylephrine, Codeine, Promethazine Phenergan  1984-04-02   
Promethazine Promethazine  1982-01-01   
Dextromethorphan, Promethazine Promethazine Dextromethorphan  1984-04-02   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
100%
2/2
Phase 3
71%
5/7
Approved: 5Overall Success rate: 71%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use